EpiVax (company)

EpiVax (company)

A computational immunology and vaccine development company based in Providence, Rhode Island. It was founded in 1998.

EpiVax is a Rhode Island-based immunology company dedicated to applying its tools (in-silico, in-vitro, and in-vivo) to re-engineering therapeutic proteins and to designing new vaccines.The company has various offerings, such as vaccine services, immunogenicity assessment, deimmunizaiton, laboratory services, and pipeline services.

COVID-19

The company has been developing a peptide-based, epitope-driven vaccine candidate for healthcare workers who are working during the COVID-19 pandemic. It has partnered with the GAIA Vaccine Foundation (GVF). The two entities are crowd-sourcing the funds and have pledged to make a free license available to developing countries who qualify for it.

The company's research is being conducted in conjunction with researchers at the University of Georgia's Center for Vaccines and Immunology.

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
EpiVax (company) Grant (money), September 2016
600,000
September 12, 2016
9 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Anne (Annie) S. De Groot, M.D.

CEO

Anthony G. Marcello

Employee

Chelsea Levesque

Employee

Clifford Grimm, MBA

CFO

Miriam Goldberg

Employee

Rebecca Martin

Employee

Sheila Chandran

Employee

William Martin

CIO

Further reading

Title
Author
Link
Type
Date

EpiVax Accelerates COVID-19 Vaccine Development with UGA's Center for Vaccines and Immunology

Web

March 4, 2020

EpiVax Partners with GAIA Vaccine Foundation to Make COVID-19 Vaccine License Free to Developing Countrie

Ulrich Martin

Web

Documentaries, videos and podcasts

Title
Date
Link

Executive Suite 10/11/2015: EpiVax CEO Annie De Groot

October 8, 2015

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Bram Berkowitz
May 1, 2020
AmericanInno
It's time for another Ocean State Update.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.